Violation Tracker Parent Company Summary

Parent Company Name: 
Sun Pharmaceuticals
Ownership Structure: 
publicly traded
Headquartered in: 
India
Major Industry: 
pharmaceuticals
Specific Industry: 
pharmaceuticals
Penalty total since 2000: 
$546,084,620
Number of records: 
8
Top 5 Offense Groups (Groups Defined)Penalty TotalNumber of Records
safety-related offenses$502,309,6204
government-contracting-related offenses$43,625,0003
competition-related offenses$150,0001
Top 5 Primary Offense TypesPenalty TotalNumber of Records
drug or medical equipment safety violation$502,300,0003
False Claims Act and related$43,625,0003
price-fixing or anti-competitive practices$150,0001
workplace safety or health violation$9,6201
Notes: 

Parent-subsidiary linkages are based on relationships current as of the latest revision listed in the Update Log, which may vary from what was the case when a violation occurred. The penalty totals are adjusted to account for the fact that the individual entries below may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. The totals are also adjusted to reflect cases in which federal and state or local agencies cooperated and issued separate announcements of the outcome. Duplicate or overlapping penalty amounts are marked with an asterisk in the list below.

Associated Names: 

DUSA Pharmaceuticals, Inc.; Ranbaxy; Ranbaxy Laboratories; Ranbaxy Pharmaceuticals, Inc.; Ranbaxy Pharmaceuticals, Inc. et al.; RANBAXY USA; SUN PHARMACEUTICAL IND

Links: 

Subsidy Tracker data on financial assistance to this company by federal, state and local government agencies can be found here.


Individual Penalty Records:

Click on the company or penalty amount for more information on each case.
Download results as CSV or XML
Company Primary Offense Type Year Agency Penalty Amountsort icon
Ranbaxy USA Inc. drug or medical equipment safety violation 2013 FDA $500,000,000
Ranbaxy drug or medical equipment safety violation 2013 MULTI-AG (*) $266,729,715
DUSA Pharmaceuticals, Inc. False Claims Act and related 2020 DOJ_CIVIL $20,750,000
Ranbaxy Pharmaceuticals, Inc. et al. False Claims Act and related 2014 TX-AG $17,875,000
Ranbaxy False Claims Act and related 2013 LA-AG $5,000,000
Ranbaxy Laboratories drug or medical equipment safety violation 2014 OR-AG $2,300,000
Ranbaxy Pharmaceuticals, Inc. price-fixing or anti-competitive practices 2014 NY-AG $150,000
SUN PHARMACEUTICAL INDUSTRIES, INC. workplace safety or health violation 2016 OSHA $9,620
Download results as CSV or XML